Genetic interference with regulators of inflammatory pathways, such as IKKβ and PPARγ, in myeloid derived cells has also been demonstrated to confer partial protection from insulin-resistance [32], [35], [36]. The gene discussed is IKBKB; the disease is Insulin resistance.